# Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome

> **NCT00159510** · PHASE1 · TERMINATED · sponsor: **Northern State Medical University** · enrollment: 28 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Methylene blue
- **DRUG:** Nitric oxide
- **DRUG:** Methylene blue & nitric oxide

## Key facts

- **NCT ID:** NCT00159510
- **Lead sponsor:** Northern State Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Inability to recruit the patients due to the short supply and changed local hospital protocol
- **Last updated:** 2015-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00159510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00159510, "Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00159510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*